![PRD_001101 PRD_001101](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/S54.svg) | PRD_001101 | Name: | N-(benzylsulfonyl)-D-valyl-N-(4-carbamimidoylbenzyl)-L-prolinamide | Formula: | C25 H33 N5 O4 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000325 PRD_000325](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0IW.svg) | PRD_000325 | Name: | Nalpha-[(4-methylpiperazin-1-yl)carbonyl]-N-[(3S)-1-phenyl-5-(phenylsulfonyl)pentan-3-yl]-L-phenylalaninamide | Formula: | C32 H40 N4 O4 S | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000326 PRD_000326](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000326.svg) | PRD_000326 | Name: | cyclo(L-alpha-aspartyl-L-tryptophyl-L-alpha-glutamyl-L-phenylalanyl-D-prolyl-L-prolyl-L-phenylalanyl-L-alpha-glutamyl-6-chloro-L-tryptophyl-L-leucyl) | Formula: | C70 H81 Cl N12 O16 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001103 PRD_001103](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001103.svg) | PRD_001103 | Name: | TMC-95A mimic ligand 2a | Formula: | C42 H47 N5 O7 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000328 PRD_000328](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0P1.svg) | PRD_000328 | Name: | N-[(benzyloxy)carbonyl]-L-alanyl-N-{(1S)-1-[(R)-[(1R)-1-benzyl-2-methoxy-2-oxoethoxy](hydroxy)phosphoryl]-3-methylbutyl
}-L-alaninamide | Formula: | C29 H40 N3 O9 P | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000329 PRD_000329](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0P2.svg) | PRD_000329 | Name: | N~2~-[(benzyloxy)carbonyl]-N-[(1R,2S)-1-(dihydroxyboranyl)-2-methylbutyl]-L-alaninamide | Formula: | C16 H25 B N2 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001105 PRD_001105](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001105.svg) | PRD_001105 | Name: | TMC-95A mimic ligand 2c | Formula: | C42 H47 N5 O8 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000330 PRD_000330](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000330.svg) | PRD_000330 | Name: | (5S,8R,11S)-8-(2-carboxyethyl)-5-(carboxymethyl)-14-(4-ethoxy-4-oxobutanoyl)-11-(1-methylethyl)-3,6,9,12-tetraoxo-1-phenyl-2-oxa-4,7,10,13,14-pentaazahexadecan-16-oic acid | Formula: | C30 H41 N5 O14 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_001107 PRD_001107](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001107.svg) | PRD_001107 | Name: | Polyphemusin analog, CXC chemokine receptor antagonist | Formula: | C95 H147 N32 O21 S2 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000331 PRD_000331](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000331.svg) | PRD_000331 | Name: | N-[(benzyloxy)carbonyl]-L-alpha-aspartyl-L-alpha-glutamyl-L-valyl-L-aspartic acid | Formula: | C26 H34 N4 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_000332 PRD_000332](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000332.svg) | PRD_000332 | Name: | Cbz-Asp-Glu-Val-AAsp-CHCH-CON(CH3)CH2Ph | Formula: | C36 H46 N6 O13 | Definition date: | 2012-12-12 | Last modified: | 2023-11-03 |
|
![PRD_000333 PRD_000333](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/0PC.svg) | PRD_000333 | Name: | Nalpha-[(benzyloxy)carbonyl]-N-[(1S)-3-chloro-1-methyl-2-oxopropyl]-L-phenylalaninamide | Formula: | C21 H23 Cl N2 O4 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001109 PRD_001109](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001109.svg) | PRD_001109 | Name: | peptide ligand | Formula: | C35 H51 Cl N6 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000334 PRD_000334](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000334.svg) | PRD_000334 | Name: | BENZYLOXYCARBONYL-GLYCYL-PHENYLALANYL-METHYLENYLGLYCYL DERIVATIVE | Formula: | C22 H24 Cl N3 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001110 PRD_001110](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/RSY.svg) | PRD_001110 | Name: | N-[(2R)-1-{[(2S,3S)-5-{[(2R)-1-{[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino}-3-chloro-1-oxopropan-2-yl]amino}-3-hydroxy-5-oxo-1-phenylpentan-2-yl]amino}-3-methyl-1-oxobutan-2-yl]pyridine-2-carboxamide | Formula: | C31 H43 Cl N6 O6 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000335 PRD_000335](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000335.svg) | PRD_000335 | Name: | DEHYDRO-ILE-ALA-ARG-SER | Formula: | C26 H42 N7 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001111 PRD_001111](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_001111.svg) | PRD_001111 | Name: | peptide ligand | Formula: | C35 H50 Cl2 N6 O10 | Definition date: | 2012-12-12 | Last modified: | 2013-06-03 |
|
![PRD_000336 PRD_000336](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000336.svg) | PRD_000336 | Name: | Cbz-Leu-Glu-Thr-AAsp-CHCH-CON-tetrahydroquinoline | Formula: | C38 H50 N6 O12 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001112 PRD_001112](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/99P.svg) | PRD_001112 | Name: | D-phenylalanyl-N-(pyridin-3-ylmethyl)-L-prolinamide | Formula: | C20 H24 N4 O2 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000337 PRD_000337](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000337.svg) | PRD_000337 | Name: | BENZYLOXYCARBONYL-LEUCINE-VALINE-GLYCINE-METHYLENE | Formula: | C22 H31 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001113 PRD_001113](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/RSZ.svg) | PRD_001113 | Name: | N-[(2S)-1-{[(2S,3S)-3-hydroxy-5-oxo-5-{[(2R)-1-oxo-3-phenyl-1-(prop-2-yn-1-ylamino)propan-2-yl]amino}-1-phenylpentan-2-yl]amino}-3-methyl-1-oxobutan-2-yl]pyridine-2-carboxamide | Formula: | C34 H39 N5 O5 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000338 PRD_000338](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000338.svg) | PRD_000338 | Name: | N-[(benzyloxy)carbonyl]-L-valyl-N-[(1S)-1-(carboxymethyl)-3-fluoro-2-oxopropyl]-L-alaninamide | Formula: | C21 H28 F N3 O7 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|
![PRD_001114 PRD_001114](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/S89.svg) | PRD_001114 | Name: | N-[(2S)-1-hydroxy-3-phenylpropan-2-yl]-Nalpha-[(2E)-3-phenylprop-2-enoyl]-L-phenylalaninamide | Formula: | C27 H28 N2 O3 | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_001115 PRD_001115](https://data.pdbjbk1.pdbj.org/pdbjplus/data/cc/svg/O61.svg) | PRD_001115 | Name: | N-[(2S)-1-({2-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]ethyl}amino)-1-oxo-3-phenylpropan-2-yl]-3-oxo-3,4-dihydro-2H-1,4-benzothiazine-7-carboxamide | Formula: | C27 H24 Cl N7 O3 S | Definition date: | 2012-12-12 | Last modified: | 2012-12-12 |
|
![PRD_000339 PRD_000339](https://data.pdbjbk1.pdbj.org/pdbjplus/data/prd/svg/PRD_000339.svg) | PRD_000339 | Name: | CARBOBENZOXY-DEHYDRO-VAL-ALA-ARG-SER | Formula: | C25 H40 N7 O8 | Definition date: | 2012-12-12 | Last modified: | 2023-09-20 |
|